HIV/AIDS: HIV RNA Control After Six Months of Potent Antiretroviral Therapy

INACTIVE REVIEW: This measure review is older than five years.

Percentage of patients aged 13 years and older with a diagnosis of HIV/AIDS, who had at least two medical visits during the measurement year, with at least 90 days between each visit, who are receiving potent antiretroviral therapy, who have a viral load < 200 copies/mL after at least 6 months of potent antiretroviral therapy

Date Reviewed: July 26, 2014
Do Not Support
    Group/Practice Individual Clinician

Measure Info

NQF 0407 CMS 162 NQF Endorsement Removed
Measure Type
Process
Measure Steward
National Committee for Quality Assurance
Clinical Topic Area
HIV
Care Setting
Outpatient
Data Source
Claims
Electronic Health Data
Electronic Health Records

ACP does not support PQRS 162: “HIV/AIDS: HIV RNA Control After Six Months of Potent Antiretroviral Therapy.” Although RNA control is a desirable outcome of HIV treatment, assessment of it at an arbitrary interval is not necessarily a measure of high quality care. The timing of assessment of clinical outcomes should be determined by patient circumstances and may differ from the interval specified.